Following this morning’s news that CareDx (CDNA) made changes to its leadership team, BTIG thinks the “biggest change” is the hiring of diagnostics industry veteran Keith Kennedy as COO. Kennedy is best known in the diagnostics world as the former COO and CFO of Veracyte (VCYT), says the firm, which regards Kennedy highly given his experience and execution in the industry and calls the addition “a positive.” The firm reiterates a Buy rating and $40 price target on CareDx shares.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CDNA:
- CareDx Announces Key Executive Appointments and Investor Day
- CareDx appoints Keith Kennedy COO, Jessica Meng CCO
- Foot Locker trips after earnings, Kohl’s posts Q2 beat: Morning Buzz
- Illumina upgraded, Fiserv initiated: Wall Street’s top analyst calls
- Wells Fargo starts tools and diagnostics group with positive bias